Investigating the Effects of Diet and Physical Activity on Esport Performance

Beneo-Institute54 enrolled

Overview

A randomized, counterbalanced intervention study in esport players.

The study will test whether i) the consumption of two different carbohydrate drinks and ii) the performance of regular high-intensity interval training will impact esport performance and metabolic profile.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

SINGLE

Enrollment

Conditions

Sports Physical Therapy Dietary Habits Diet, Healthy

Interventions

Low glycaemic indexDIETARY_SUPPLEMENT

Diet will be supplemented with a drink containing a low glycaemic index carbohydrate

High glycaemic indexDIETARY_SUPPLEMENT

Diet will be supplemented with a drink containing a high glycaemic index carbohydrate

Physical activityBEHAVIORAL

Participants will include physical activity units

Eligibility

Sex: ALLMin age: 18 YearsMax age: 45 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Informed consent obtained * Male or female aged 18-45 years * Healthy * Participants have to be part of an esport association and/or regularly participate in tournaments Exclusion Criteria: * diabetes mellitus type 1 or 2 (T1DM or T2DM) * medication which impacts glucose metabolism or visual perception * health issues like cardiovascular diseases, severe orthopaedic conditions or neurological impairments * food allergies or intolerances, e.g. fructose malabsorption

Locations (1)

German Sports University Cologne

Cologne, Germany

Outcomes

Primary Outcomes

Change in esport performance (test battery)

Reaction time will be measured using an esport test battery

Time frame: 4 weeks

Secondary Outcomes

Glucose response (continuous glucose monitor): 3h iAUC

The 3h incremental area under the curve (iAUC) will be used to assess glycemic response to the drink. Unit: mg/dL

Time frame: 4 weeks

Glycaemic variability (continuous glucose monitor): 24h MAGE

The mean amplitude of glycemic excursion during 24h will be assessed as an indicator for glycemic variability. Unit: mg/dL

Time frame: 4 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.